Aerovate Therapeutics Inc (AVTE) PT Raised to $32 at Wedbush
Tweet
Share
E-mailGet Alerts AVTE Hot Sheet
Price: $2.68 --0%
Rating Summary:
0 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
0 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Wedbush analyst Liana Moussatos raised the price target on Aerovate Therapeutics Inc (NASDAQ: AVTE) to $32.00 (from $23.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- JPMorgan Downgrades Bukit Asam Tbk PT (PTBA:IJ) to Underweight
- Sembcorp Industries (SCI:SP) PT Lowered to SGD6.39 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
